Except for primary resistant tumour BoC117 (Fig. S9A), all analysed tumours showed an increase of phosphorylated ERK (pERK) at the EOT compared to day 5 irrespective of being primary or SR. This evidence concerns the gene EIF2AK3 and neoplasm.